Shareholders Equity and Capital Stock (Details 7) |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
$ / shares
shares
| |
Exercise price $1.00 | |
Exercise price | $ / shares | $ 1.00 |
Number of warrants | shares | 13,062,878 |
Remaining contractual life (years) | 6 months |
Aggregate Intrinsic Value | $ | $ 653,144 |
Expiry | Sep. 25, 2021 |
Exercise price $0.75 | |
Exercise price | $ / shares | $ 0.75 |
Number of warrants | shares | 8,038,000 |
Remaining contractual life (years) | 1 year 3 months 18 days |
Aggregate Intrinsic Value | $ | $ 1,406,650,000 |
Expiry | Aug. 04, 2022 |
Exercise price $1.35 | |
Exercise price | $ / shares | $ 1.35 |
Number of warrants | shares | 16,930,530 |
Remaining contractual life (years) | 2 years 9 months 18 days |
Aggregate Intrinsic Value | $ | $ 0 |
Expiry | Feb. 04, 2024 |
Exercise price $1.10 | |
Exercise price | $ / shares | $ 1.10 |
Number of warrants | shares | 38,031,408 |
Remaining contractual life (years) | 1 year 8 months 12 days |
Aggregate Intrinsic Value | $ | $ 2,059,794,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|